Synthetic Biologics, Inc. (SYN)
EBITDA Growth
74.71%
Quarterly · Period ending:
SYN EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported74.71%period ending
Latest reported74.71%period ending
SYN Quarterly EBITDA YoY % (62.03% → 74.71%)
Year-over-year change
High-resolution chart · PNG
SYN ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -106.25% | |
| -62.5% | |
| -10.5263% | |
| 27.8846% | |
| 15.3439% | |
| -15.1079% | |
| -10.4651% | |
| -34.1935% | |
| -22.7273% | |
| -363.3333% | |
| -43.3333% | |
| -10.7143% | |
| -285% | |
| 0% | |
| -130.7692% | |
| -1,455.5556% | |
| 27.2727% | |
| 62.0253% |